| Revenue growth | 38.2% YoY reported; 40.0% YoY on LFL basis. |
|---|---|
| Margins | Gross margin up 147bps to 11.4%; EBITDA margin reached 5.0%. |
| Demand visibility | Organic growth running ahead of IPM growth. |
| Management confidence | High confidence on delivering on guidance for rest of the year. |
Growth
Revenue rose 38% YoY; EBITDA increased 94% to ₹97 Cr; PAT (to owners) grew 37% to ₹38.2 Cr.
Outlook
MedTech revenue expected to cross ₹1,000 Cr in FY27. High confidence in delivering on guided trajectory.
Risks
Fragmented market competition and potential impact from conscious exits in certain low-margin businesses.
Last quarter's promises, checked
Delivered
- Guided 30% LFL revenue growth → delivered 31.5% (= BEAT)
- Guided 4% EBITDA margin → delivered 4% (= BEAT)
- Guided operating cash flow optimization → delivered ₹96.2 Cr OCF (= BEAT)
Investor Presentation filed with BSE, NSE: ENTERO. Summary written with AI assistance from the document.
Entero Healthcare Solutions Ltd: key numbers
- Share price
- ₹1,821.80
- Market cap
- ₹7,929 Cr
- Revenue (annual)
- ₹6,591 Cr
- Net profit (annual)
- ₹115.0 Cr
- P/E (TTM)
- 63.2×Sector 57.8×
- Promoter holding
- 52.40%-0.02% QoQ
- FII holding
- 4.36%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Entero Healthcare Solutions Ltd
All →Entero Healthcare Solutions Capital Structure Change
Surbhi Singh (Prasid Uno Family Trust), a non-promoter, sold 21.30 lakh Entero Healthcare shares via bulk/block deals. Stake fell from 7.94% to 3.05%; no transaction value disclosed.
Entero Healthcare Solutions Legal & Regulatory
Entero Healthcare Solutions reported a GST penalty of Rs. 0.13 Crore imposed on its subsidiary, ACE Cardiopathy Solutions, for non-generation of an E-Invoice.
- Value
- ₹0.13 Cr
Entero Healthcare Solutions Other Announcement
Entero Healthcare Solutions Ltd filed its quarterly shareholding pattern for the period ended March 31, 2026, as per regulatory requirements.
Entero Healthcare Solutions Earnings Call Transcript: Key Takeaways
Entero delivered a strong Q1 FY27 with 38.2% revenue growth and hit its full-year EBITDA margin target of 5% in the first quarter itself, signaling rapid structural margin expansion.
- Call
- Guides 23% growth
Entero Healthcare Solutions Q1 FY27 Results: Net Profit ₹52.1 Cr, Up 72.5% YoY
Entero Healthcare Solutions Ltd reported revenue from operations of ₹1,940 Cr (+38.2% YoY) and net profit of ₹52.1 Cr (+72.5% YoY) for Q1 FY27.
- Key figure
- Net profit ₹52.1 Cr · +72.5% YoY
Entero Healthcare Solutions Earnings Call: Key Takeaways
Entero delivered solid FY26 results, meeting all guidance parameters. Management transitions focus toward organic growth and margin expansion through technology-led scaling and higher-margin MedTech distribution.